Entecavir and peginterferon alfa-2a in adults with HBeAg-positive immune tolerant chronic hepatitis B virus infection

BACKGROUND/AIM: Monotherapy with interferon or nucleoside analog is generally not recommended during the immune tolerant (IT) phase of chronic hepatitis B virus (HBV) infection. Recognition that high HBV DNA levels are associated with hepatocellular carcinoma has increased interest in treating HBV i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hepatology
Autors principals: Feld, Jordan J., Terrault, Norah A., Lin, Hsing-Hua S., Belle, Steven H., Chung, Raymond T., Tsai, Naoky, Khalili, Mandana, Perrillo, Robert, Cooper, Stewart L., Ghany, Marc G., Janssen, Harry L.A., Lok, Anna S.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6541521/
https://ncbi.nlm.nih.gov/pubmed/30549279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.30417
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars